Thomas Shilling
Directeur Financier/CFO chez Molecular Diagnostics & Therapeutics, Inc.
Profil
Thomas Shilling is currently the Chief Financial Officer at Molecular Diagnostics & Therapeutics, Inc. He holds a Master's in Business Administration from Drake University.
Postes actifs de Thomas Shilling
| Sociétés | Poste | Début |
|---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
 Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Directeur Financier/CFO | 01/07/2001 |
Formation de Thomas Shilling
| Drake University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Molecular Diagnostics & Therapeutics, Inc.
Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |
